ID

27528

Description

Study part: Concomitant Medication Treatment Phase. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

  1. 11/19/17 11/19/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

November 19, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Concomitant Medication Treatment Phase Ropinirole Parkinson Disease 101468/165

Concomitant Medication Treatment Phase

CONCOMITANT MEDICATION
Description

CONCOMITANT MEDICATION

Alias
UMLS CUI-1
C2347852
Patient Number
Description

Patient Number

Data type

integer

Alias
UMLS CUI [1]
C1830427
Are there any concomitant medication changes since the start of the study?
Description

Concomitant Medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Drug Name
Description

Drug Name

Data type

text

Alias
UMLS CUI [1]
C0013227
Single dose/Unit
Description

Single dose

Data type

text

Alias
UMLS CUI [1]
C1960417
Frequency of this dose
Description

dose frequency

Data type

text

Alias
UMLS CUI [1]
C2826654
Route
Description

Route

Data type

text

Alias
UMLS CUI [1]
C0013153
Indication
Description

Indication

Data type

text

Alias
UMLS CUI [1]
C3146298
Start Date/Time
Description

Start Date and Time

Data type

datetime

Alias
UMLS CUI [1]
C3897500
End Date/Time
Description

End Date and Time

Data type

datetime

Alias
UMLS CUI [1]
C3899266

Similar models

Concomitant Medication Treatment Phase

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
CONCOMITANT MEDICATION
C2347852 (UMLS CUI-1)
Patient Number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Concomitant Medication
Item
Are there any concomitant medication changes since the start of the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Single dose
Item
Single dose/Unit
text
C1960417 (UMLS CUI [1])
dose frequency
Item
Frequency of this dose
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date and Time
Item
Start Date/Time
datetime
C3897500 (UMLS CUI [1])
End Date and Time
Item
End Date/Time
datetime
C3899266 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial